Direct-Acting Antiviral Medicines Market Trends

  • Report ID: 3005
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Direct-Acting Antiviral Medicines Market Trends

Growth Drivers

  • Increasing Prevalence of Liver Cirrhosis and Hepatocellular Carcinoma
  • Growing Investment in the Development of Advanced Therapies

Challenges

  • Low Access to Direct-Acting Antiviral Medicines in Low Economic Regions
  • Side Effects of Direct-Acting Antiviral Medicines

Direct-Acting Antiviral Medicines Market: Key Insights

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific is predicted to grow at the highest CAGR over the forecast period owing to the increasing hepatitis C infection prevalence and rising focus of major companies for expanding their product to countries in the region. Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue, owing to high awareness about direct-acting antiviral medicines in the region, accompanied by the presence of leading healthcare service providers in the region. Along with this, the North America also leads in terms of reimbursement policy system, which is also expected to contribute to the market growth in the region. Alternatively, the market in Europe is also anticipated to occupy a significant share in the direct-acting antiviral medicines market on account of increase in number of patients with hepatitis C infection & lung cancer along with presence of large pharmaceutical companies. As per the analysis of World Health Organization, Europe is one of the most affected region by Hepatitis C infection, where approximately 14 million people are chronically infected with Hepatitis C, leading to about 112,500 deaths per year from Hepatitis C-related liver cancer and cirrhosis.

Direct-Acting-Antiviral-Medicines-Market-Share

The direct-acting antiviral medicines market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Base Year

2024

Regional Scope

2025-2037

CAGR

Base Year Market Size (2024)

Forecast Year Market Size (2037)

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3005
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Direct-Acting Antiviral Medicines Market size is likely to register remarkable growth rate during the forecast period i.e., between 2025-2037.

Increasing prevalence of liver cirrhosis and hepatocellular carcinoma and the growing investment in the development of advanced therapies will drive the market growth.

Asia Pacific industry is set to account for largest revenue share by 2037, owing to increasing hepatitis C infection prevalence and rising focus of major companies for expanding their product to countries in the region.

The major players in the market are AbbVie, Inc., Janssen Therapeutics, Bristol-Myers Squibb, and Merck & Co., among others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample